Griffin Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-739
Closed -$230K 208
2025
Q1
$230K Buy
+739
New +$218K 0.03% 191
2024
Q4
Sell
-760
Closed -$245K 214
2024
Q3
$245K Sell
760
-197
-21% -$64.4K 0.03% 194
2024
Q2
$299K Buy
957
+46
+5% +$13.5K 0.03% 185
2024
Q1
$259K Buy
911
+100
+12% +$29.3K 0.03% 203
2023
Q4
$234K Hold
811
0.03% 199
2023
Q3
$218K Buy
+811
New +$202K 0.03% 189
2023
Q1
Sell
-929
Closed -$244K 211
2022
Q4
$244K Buy
+929
New +$249K 0.04% 193
2019
Q3
Sell
-328
Closed -$60K 240
2019
Q2
$60K Buy
+328
New +$58.7K 0.01% 345

Other funds holding AMGN

Griffin Asset Management's AMGN Position: Q2 2025 in Review

Griffin Asset Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 739 shares — an estimated $230K sold.

Griffin Asset Management first reported a position in AMGN in Q2 2019 and held it in 8 quarters. The position peaked at $299K in Q2 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Griffin Asset Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Griffin Asset Management sold 739 Amgen shares in Q2 2025, an estimated $230K.
  • Griffin Asset Management first reported a position in Amgen in Q2 2019 and held it in 8 quarters.
  • Griffin Asset Management's Amgen position peaked at $299K in Q2 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Griffin Asset Management's 13F filing for Q2 2025, filed 25 Jul 2025.